Phase 3 Study to Assess the Long-Term Safety and Efficacy of JTZ-951 in Anemic Patients with Chronic Kidney Disease Receiving Maintenance Hemodialysis <Long-Term Study> (SYMPHONY HD-Long)
Latest Information Update: 10 Jan 2022
At a glance
- Drugs Enarodustat (Primary)
- Indications Anaemia
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms SYMPHONY HD-Long
- Sponsors Japan Tobacco
- 02 Dec 2021 Status changed from active, no longer recruiting to completed.
- 13 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 07 Nov 2017 New trial record